Perbedaan Kadar Prostaglandin F2α Cairan Darah Haid (Menstrual Fluid) Pada Dismenore Primer, Sekunder Dan Non Dismenore
DAFTAR PUSTAKA
1.
Morrow C, Naumburg E, Dysmenorrhea, Morrow & Naumburg, 2009
2.
Khorsidi N, Ostad SN, Mossadegh M, Soodi M. Clinical effects of fennel
essential oil on primary dysmenorrhea. Iranian Journal Of Pharmaceutical
Research 2003; 89-93
3.
Banikarim C, Chacko MR, Kelder SH. Prevalence and impact of
dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med
2000; 154; 1226-29
4.
Dawood MY. Primary dysmenorrhea advances in pathogenesis and
management, 2006;108:428-41
5.
Burnett MA, Antao V, Black A, Feldman K, Grenville A, Lea R, et al.
Prevalence of primary dysmenorrhea in Canada, J Obstet Gynaecol Can
2005;27:765-70
6.
Dawood MY. Dysmenorrhea, Current Obstetrics and Gynecology
1993;3:219-224
7.
Kang J, Akoum A, Chapdelaine P, Laberge P, Poubelle PE, Fortier MA.
Independent regulation of prostaglandins and monocyte chemoattractant
protein-1 by interleukin-1b and hCG in human endometrial cells. Human
Reproduction 2004;19:2465–2473
8.
Dawood MY, Khan-Dawood FS.Clinical efficacy and differential inhibition
of menstrual fluid prostaglandin F2α, in randomized, double blind,
42
lx
Universitas Sumatera Utara
crossover treatment with placebo, acetaminophen, and ibuprofen in
primary dysmenhorrea. Am J Obstet Gynecol 2007; 196;35.e1-35.e5
9.
Christie WW. Prostanoids-prostaglandins, prostacyclins and tromboxanes:
chemistry and biology
10.
Auld B, Sinha P. Dysmenorrhoea: features and current treatment options.
Drug review dysmenorrhea. 2006; 33-40
11.
Dawood MY. Dysmenorrhoea and prostaglandins: pharmacological and
therapeutic considerations. ADIS Press Australasia Pty Ltd.1981;42-56
12.
Charu S, Amita R, Sujoy R et all. „Menstrual characteristics‟ and
„Prevalensi and effect of dysmenorrhea‟ on quality of life of medical
students. International Journal of Collaborative research on Internal
Medicine & Public Health. 2013; vol.4 no 4: 276-294
13.
Hudson T. Using nutrition to relieve primary dysmenhorrea. Alternative
and complementary therapies. 2007
14.
Zahradnika HP, Becka AH, Grothb K. Nonsteroidal anti-inflammatory
drugs and hormonal contraceptives for pain relief from dysmenorrhea: a
review. Contraception 2010;81:185-96
15.
Unkels R. Painful Menstrual Period: Dysmenorrhea
16.
Kaplan O, Naziroglu M et al. Non-Steroidal Anti-Inflammatory Drug
Modulates Oxidative Stress and Calcium Ion Levels in The Neutrophils of
Patients With Primary Dysmenorrhea. Journal Reproductive Immunology
100 (2014) 87-92
43 lxi
Universitas Sumatera Utara
17.
Kumbhar SK, Reddy M etall. Prevalensi of Dysmenorrhea Among
Adolescent Girls (15-19 yrs) of Kadapa District and its Impact on Quality of
Life: A Cross Sectional Study. National Journal of Community Medicine
Vol 2 Issue 2 July- Sept 2012
18.
Ozerdogan N, Deniz S, Ayranci U etall. Prevalensi and Predictor of
Dysmenorrhea Among Student at a University in Turkey. International
Journal of Gynecology and Obstetrics 107 (2009) 39-43
19.
Sundell G, Milsom I, Andersch B. Factor influencing the prevalence and
severity of dysmenorrhea in young women. Br J Obstet Gynaecol. 1990;
97; 588-594
20.
Parazzini F, Tozzi L, Mezzopane R, et al. Cigarette smoking, alcohol
consumption and risk of primary dysmenorrhea. Epidemiology. 1994; 5;
469-472.
21.
Garvin JH. The influence of the hormonal milieu on eicosanoid and
cytokine production in tissues from the female reproductive tract. 2012
22.
Eby GA. Zinc treatment prevents dysmenorrhea. Medical Hypotheses
2007; 69; 297-301
23.
Powel AM, Chan WY, Alvin P, Litt IF. Menstrual PGF2α, PGE2, and TXA in
normal and dysmenorrheic women and their temporal relationship to
dysmenorrhea. Prostaglandins 1985;15; 273-289
24.
Bieglmayer C, Hofer G,Kainz C, Reinthaller A et al. Concentrations of
various arachidonic acid metabolites in menstrual fluid are associated with
44
lxii
Universitas Sumatera Utara
menstrual pain and are influenced by hormonal contraceptives. Gynecol
Endocrinol 1995; 9; 307-12
25.
Coulthard G, Erb W, Aggarwal VK. Stereocontrolled organocataliytic
synthesis of prostaglandin PGF2α in seven steps. Nature 2012; 489; 27881
26.
Sorensen EJ. A biochemical messenger made easily. Nature 2012; 489;
214-15
27.
Ruan Ye Chun, Zhou Wenliang, Chan Hsiao Chang. Regulation of smooth
muscle contraction by the epithelium: role of prostaglandins. Physiology
2011; 26; 156-170
28.
Simmons DL, Botting RM, HLA Timothy. Cyclooxygenase isozymes: the
biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004;
56: 387-437
29.
Funk Colin D. Prostaglandins and leukotrienes: advances in eicosanoid
biology. Science 2001; 294: 1871-75
30.
Smith WL, Murphy RC. The eicosanoids: cyclooxygenase, lipoxygenase,
and epoxygenase pathways
31.
Zeldin DC. Epoxygenase pathways of arachidonic acid metabolism. The
Journal of Biological Chemistry 2001; 276; 36059-62
32.
Sales KJ, Jabbour HN. Cyclooxygenase enzymes and prostaglandins in
pathology of the endometrium. Reproduction 2003; 126; 559-67
45lxiii
Universitas Sumatera Utara
33.
Aros JA, Banu SK, Chapdelaine P, Madore E et al. Prostaglandin
biosynthesis, transport, and signaling in corpus luteum: A basis for
autoregulation of luteal function. Endocrinology 2004; 145; 2551-2560
34.
Ricciotti
E,
Fitzgerald
GA.
Prostaglandins
and
inflammation.
Arterioscler thromb vasc biol 2011; 31; 986-100
lxiv
46
Universitas Sumatera Utara
1.
Morrow C, Naumburg E, Dysmenorrhea, Morrow & Naumburg, 2009
2.
Khorsidi N, Ostad SN, Mossadegh M, Soodi M. Clinical effects of fennel
essential oil on primary dysmenorrhea. Iranian Journal Of Pharmaceutical
Research 2003; 89-93
3.
Banikarim C, Chacko MR, Kelder SH. Prevalence and impact of
dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med
2000; 154; 1226-29
4.
Dawood MY. Primary dysmenorrhea advances in pathogenesis and
management, 2006;108:428-41
5.
Burnett MA, Antao V, Black A, Feldman K, Grenville A, Lea R, et al.
Prevalence of primary dysmenorrhea in Canada, J Obstet Gynaecol Can
2005;27:765-70
6.
Dawood MY. Dysmenorrhea, Current Obstetrics and Gynecology
1993;3:219-224
7.
Kang J, Akoum A, Chapdelaine P, Laberge P, Poubelle PE, Fortier MA.
Independent regulation of prostaglandins and monocyte chemoattractant
protein-1 by interleukin-1b and hCG in human endometrial cells. Human
Reproduction 2004;19:2465–2473
8.
Dawood MY, Khan-Dawood FS.Clinical efficacy and differential inhibition
of menstrual fluid prostaglandin F2α, in randomized, double blind,
42
lx
Universitas Sumatera Utara
crossover treatment with placebo, acetaminophen, and ibuprofen in
primary dysmenhorrea. Am J Obstet Gynecol 2007; 196;35.e1-35.e5
9.
Christie WW. Prostanoids-prostaglandins, prostacyclins and tromboxanes:
chemistry and biology
10.
Auld B, Sinha P. Dysmenorrhoea: features and current treatment options.
Drug review dysmenorrhea. 2006; 33-40
11.
Dawood MY. Dysmenorrhoea and prostaglandins: pharmacological and
therapeutic considerations. ADIS Press Australasia Pty Ltd.1981;42-56
12.
Charu S, Amita R, Sujoy R et all. „Menstrual characteristics‟ and
„Prevalensi and effect of dysmenorrhea‟ on quality of life of medical
students. International Journal of Collaborative research on Internal
Medicine & Public Health. 2013; vol.4 no 4: 276-294
13.
Hudson T. Using nutrition to relieve primary dysmenhorrea. Alternative
and complementary therapies. 2007
14.
Zahradnika HP, Becka AH, Grothb K. Nonsteroidal anti-inflammatory
drugs and hormonal contraceptives for pain relief from dysmenorrhea: a
review. Contraception 2010;81:185-96
15.
Unkels R. Painful Menstrual Period: Dysmenorrhea
16.
Kaplan O, Naziroglu M et al. Non-Steroidal Anti-Inflammatory Drug
Modulates Oxidative Stress and Calcium Ion Levels in The Neutrophils of
Patients With Primary Dysmenorrhea. Journal Reproductive Immunology
100 (2014) 87-92
43 lxi
Universitas Sumatera Utara
17.
Kumbhar SK, Reddy M etall. Prevalensi of Dysmenorrhea Among
Adolescent Girls (15-19 yrs) of Kadapa District and its Impact on Quality of
Life: A Cross Sectional Study. National Journal of Community Medicine
Vol 2 Issue 2 July- Sept 2012
18.
Ozerdogan N, Deniz S, Ayranci U etall. Prevalensi and Predictor of
Dysmenorrhea Among Student at a University in Turkey. International
Journal of Gynecology and Obstetrics 107 (2009) 39-43
19.
Sundell G, Milsom I, Andersch B. Factor influencing the prevalence and
severity of dysmenorrhea in young women. Br J Obstet Gynaecol. 1990;
97; 588-594
20.
Parazzini F, Tozzi L, Mezzopane R, et al. Cigarette smoking, alcohol
consumption and risk of primary dysmenorrhea. Epidemiology. 1994; 5;
469-472.
21.
Garvin JH. The influence of the hormonal milieu on eicosanoid and
cytokine production in tissues from the female reproductive tract. 2012
22.
Eby GA. Zinc treatment prevents dysmenorrhea. Medical Hypotheses
2007; 69; 297-301
23.
Powel AM, Chan WY, Alvin P, Litt IF. Menstrual PGF2α, PGE2, and TXA in
normal and dysmenorrheic women and their temporal relationship to
dysmenorrhea. Prostaglandins 1985;15; 273-289
24.
Bieglmayer C, Hofer G,Kainz C, Reinthaller A et al. Concentrations of
various arachidonic acid metabolites in menstrual fluid are associated with
44
lxii
Universitas Sumatera Utara
menstrual pain and are influenced by hormonal contraceptives. Gynecol
Endocrinol 1995; 9; 307-12
25.
Coulthard G, Erb W, Aggarwal VK. Stereocontrolled organocataliytic
synthesis of prostaglandin PGF2α in seven steps. Nature 2012; 489; 27881
26.
Sorensen EJ. A biochemical messenger made easily. Nature 2012; 489;
214-15
27.
Ruan Ye Chun, Zhou Wenliang, Chan Hsiao Chang. Regulation of smooth
muscle contraction by the epithelium: role of prostaglandins. Physiology
2011; 26; 156-170
28.
Simmons DL, Botting RM, HLA Timothy. Cyclooxygenase isozymes: the
biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004;
56: 387-437
29.
Funk Colin D. Prostaglandins and leukotrienes: advances in eicosanoid
biology. Science 2001; 294: 1871-75
30.
Smith WL, Murphy RC. The eicosanoids: cyclooxygenase, lipoxygenase,
and epoxygenase pathways
31.
Zeldin DC. Epoxygenase pathways of arachidonic acid metabolism. The
Journal of Biological Chemistry 2001; 276; 36059-62
32.
Sales KJ, Jabbour HN. Cyclooxygenase enzymes and prostaglandins in
pathology of the endometrium. Reproduction 2003; 126; 559-67
45lxiii
Universitas Sumatera Utara
33.
Aros JA, Banu SK, Chapdelaine P, Madore E et al. Prostaglandin
biosynthesis, transport, and signaling in corpus luteum: A basis for
autoregulation of luteal function. Endocrinology 2004; 145; 2551-2560
34.
Ricciotti
E,
Fitzgerald
GA.
Prostaglandins
and
inflammation.
Arterioscler thromb vasc biol 2011; 31; 986-100
lxiv
46
Universitas Sumatera Utara